TY - JOUR

T1 - Prescription charge policy acceptance among UK adults with and without long-term health conditions

T2 - a mixed-method survey

AU - Readman, M.R.

AU - Polden, M.

AU - Brighton, L.

AU - Oluseye, A.

AU - Fairman, I.

AU - Parkinson, I.

AU - Parkinson, C.

AU - Giebel, C.

PY - 2024/9/24

Y1 - 2024/9/24

N2 - Objectives Since their introduction in 1952, per-prescribed item charges in England have continually risen. This study investigated the acceptability and impact of per-prescribed item charges, and awareness and use of initiatives designed to reduce prescription charge financial burden (the prescription prepayment certificate (PPC) initiative), in people living with and without long-term health conditions (LTHCs) in the UK.Design Cross-sectional mixed-method survey of people with and without an LTHC across the UK.Participants 381 people, 267 people with an LTHC and 114 people without an LTHC, participated.Outcome measures Acceptability and impact of prescription charge policy, awareness and use of the PPC.Results Over half (53.2 %) of participants disagreed with current per-prescribed item charges. In most domains, the impact of prescription charges did not differ between people with and without LTHCs. However, people with LTHCs were more likely to report financial burden and deviate from prescribed medication regimes. 35.29% of respondents were aware of the PPC, with people with LTHCs being more likely to be aware of and use this initiative. Qualitative findings indicate perceived inequalities in current policy with themes including (1) the need for re-evaluation; (2) the burden of prescription charges; (3) inconsistencies and inequalities in current policy; and (4) positive reflections of prescription charge policy.Conclusions Inconsistencies in current policy and a lack of public support may suggest that a re-evaluation of current policy is required. The lack of difference in the impact of prescription charge policy between people with and without LTHCs indicates that the effects of such policy are not constrained to people with LTHCs. Thus, policy amendments would benefit the wider population. Systematic efforts to increase awareness of the PPC and reduce inequalities in medical exemption criteria are suggested.

AB - Objectives Since their introduction in 1952, per-prescribed item charges in England have continually risen. This study investigated the acceptability and impact of per-prescribed item charges, and awareness and use of initiatives designed to reduce prescription charge financial burden (the prescription prepayment certificate (PPC) initiative), in people living with and without long-term health conditions (LTHCs) in the UK.Design Cross-sectional mixed-method survey of people with and without an LTHC across the UK.Participants 381 people, 267 people with an LTHC and 114 people without an LTHC, participated.Outcome measures Acceptability and impact of prescription charge policy, awareness and use of the PPC.Results Over half (53.2 %) of participants disagreed with current per-prescribed item charges. In most domains, the impact of prescription charges did not differ between people with and without LTHCs. However, people with LTHCs were more likely to report financial burden and deviate from prescribed medication regimes. 35.29% of respondents were aware of the PPC, with people with LTHCs being more likely to be aware of and use this initiative. Qualitative findings indicate perceived inequalities in current policy with themes including (1) the need for re-evaluation; (2) the burden of prescription charges; (3) inconsistencies and inequalities in current policy; and (4) positive reflections of prescription charge policy.Conclusions Inconsistencies in current policy and a lack of public support may suggest that a re-evaluation of current policy is required. The lack of difference in the impact of prescription charge policy between people with and without LTHCs indicates that the effects of such policy are not constrained to people with LTHCs. Thus, policy amendments would benefit the wider population. Systematic efforts to increase awareness of the PPC and reduce inequalities in medical exemption criteria are suggested.

U2 - 10.1136/bmjopen-2024-085345

DO - 10.1136/bmjopen-2024-085345

M3 - Journal article

VL - 14

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 9

M1 - e085345

ER -